Skip to main content

Table 5 Treatment priorities, in response to the case vignettes, compared between respiratory medicine (RM) and palliative care (PC) physicians

From: Do guidelines influence breathlessness management in advanced lung diseases? A multinational survey of respiratory medicine and palliative care physicians

 

COPD

fILD

LC

RM (n = 336)

PC (n = 95)

Specialties compared (χ2)

p value

RM (n = 324)

PC (n = 87)

Specialties compared (χ2)

p value

RM (n = 300)

PC (n = 102)

Specialties compared (χ2)

p value

Drug treatment for breathlessness

70 (21%)

52 (55%)

p < 0.001

78 (24%)

35 (40%)

p < 0.001

174 (58%)

76 (75%)

p = 0.001

Re-assess oxygen prescription

29 (9%)

2 (2%)

79 (24%)

3 (3%)

23 (8%)

1 (1%)

Non-pharmacological, non-exercise intervention

28 (8%)

25 (26%)

28 (9%)

24 (28%)

29 (10%)

15 (15%)

Exercise training / rehabilitation

166 (49%)

7 (7%)

96 (30%)

16 (18%)

10 (3%)

1 (1%)

Psychological assessment to explore co-existing anxiety and/or depression

31 (9%)

5 (5%)

30 (9%)

6 (7%)

58 (19%)

7 (7%)

Other

12 (4%)

4 (4%)

13 (4%)

3 (3%)

6 (2%)

2 (2%)

  1. Percentages > or < 100% are due to rounding
  2. COPD, Chronic Obstructive Pulmonary Disease; fILD, Fibrotic Interstitial Lung Disease; LC, Lung Cancer; PC, Palliative Care; RM, Respiratory Medicine